ArticleAdvanced pharmaceutical bulletin2021

The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells.

Edy Meiyanto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.